What does 'Research Use Only' mean?

Research Use Only (RUO) is a legal category for compounds sold as chemical reagents for scientific investigation rather than as therapeutic drugs. Products labelled RUO are not subject to the same manufacturing quality controls (cGMP) as approved drugs, are not required to meet identity or potency specifications appropriate for human use, and are not authorised for any human therapeutic indication anywhere.

Many of the peptides in this catalog are sold through RUO channels — BPC-157, TB-500, MOTS-c, kisspeptin, DSIP, Selank, Semax, KPV, and others. This does not mean the compound is 'illegal', but it does mean the compound has not passed the regulatory bar that would establish safety and effectiveness for human clinical use. RUO products can vary substantially in identity verification, purity, and potency between suppliers because they are not held to pharmaceutical-grade specifications.

The FDA's 2023 addition of BPC-157 to a list of substances of concern for compounding pharmacies is an example of RUO status meeting regulatory scrutiny. The addition doesn't ban BPC-157; it signals that FDA does not consider it appropriate for compounding into human-injectable preparations without more clinical evidence.

When a compound page notes RUO status, the honest framing is that the compound sits in a regulatory space that is legally distinct from approved-drug status and does not carry the safety and effectiveness guarantees that FDA approval provides. Users should read those pages as scientific reference rather than as clinical recommendations.